DIAGNOSTIC ACCURACY AND ADDED VALUE OF INFECTION BIOMARKERS IN PATIENTS WITH POSSIBLE SEPSIS IN THE EMERGENCY DEPARTMENT.
Erik E Christensen, Christina Binde, Marianne Leegaard...
https://pubmed.ncbi.nlm.nih.gov/36130401/Actively Recruiting
Led by Oslo University Hospital · Updated on 2026-03-19
1950
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are conducting a prospective observational study to evaluate biomarkers, molecular biology methods, and other analyses in the blood of adults suspected of having sepsis in the Emergency Department. The study aims to better understand sepsis and identify new sepsis subtypes by enrolling about 1500 patients over a five-year period at Oslo University Hospital, Ullevl. Patients initially treated for possible sepsis but later found to have other conditions will serve as controls. Eligible patients are adults over 18 years admitted to the emergency department and managed by either the medical rapid response team or the sepsis rapid response team. Consent is collected at the emergency department or shortly afterward by clinical investigators or study nurses. The study focuses on adults suspected of sepsis and follows their clinical course and biomarker changes during their hospital stay. Participants will undergo blood sampling to measure biomarkers such as plasma-calprotectin and bacterial DNA, with evaluations done over one year. Researchers will assess inflammation biomarkers accuracy in detecting infections in critically ill patients. Study involvement includes monitoring biomarker levels and molecular changes in blood, aiming to improve sepsis diagnosis and personalized care approaches. Safety and consent are carefully managed throughout the study period.
CONDITIONS
Sepsis: From Syndrome to Personalized Care
A
Aleksander R Holten, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Oslo University Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Initial hospital admission period
Participants suspected of sepsis are assessed and classified based on their condition.
Visits during hospital stay as part of routine care
Duration - Up to 1 year
Participants are observed for up to one year to monitor biomarkers and infection status.
Follow-up visits and assessments over one year
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Erik E Christensen, Christina Binde, Marianne Leegaard...
https://pubmed.ncbi.nlm.nih.gov/36130401/Oslo University Hospital
Lead Sponsor